featured
Low-Dose Lenalidomide Is Effective and Less Toxic in Older Patients With Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Upfront Lower Dose Lenalidomide Is Less Toxic and Does Not Compromise Efficacy for Vulnerable Patients With Relapsed Refractory Multiple Myeloma: Final Analysis of the Phase II RevLite Study
Br. J. Haematol 2017 Feb 15;[EPub Ahead of Print], H Quach, L Fernyhough, R Henderson, G Corbett, B Baker, P Browett, H Blacklock, C Forsyth, C Underhill, P Cannell, J Trotman, A Neylon, S Harrison, E Link, A Swern, L Cowan, MA Dimopoulos, HM PrinceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.